bullish
Gilead to Acquire a Stake in Arcus Biosciences; Offer May Come at a Large Premium
345 Views21 Apr 2020 11:54
On 16th April 2020, Bloomberg reported that Gilead Sciences is considering acquiring a significant stake in Arcus Biosciences, a cancer...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Boqii IPO: Intense Price Competition Impacts Top Line Growth and Eat into Margins30 Sep 2020
- Gilead: Will Immunomedics Be Gilead’s Next Pharmasset?30 Sep 2020
- Gilead to Acquire a Stake in Arcus Biosciences; Offer May Come at a Large Premium21 Apr 2020
- Terumo: Not Just an Opportune COVID Play but a Business with Solid Long-Term Prospects20 Apr 2020
- Palo Alto Buys Cloud Services Firm CloudGenix to Make Up for Declining Legacy Hardware Business07 Apr 2020
- M3 Inc: M&A Deals to Support Global Expansion While Medical Platform Offers Solid LT Growth27 Mar 2020
x